NCT07564141
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07564141
Title Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer (RAINFOL-07)
Acronym RAINFOL-07
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Danbury Hospital RECRUITING Danbury Connecticut 06810 United States Details
Compass Oncology - West Cancer Center (Northwest Cancer Specialists, P.C.) RECRUITING Tigard Oregon 97223 United States Details
Alliance Cancer Specialists, PC RECRUITING Bensalem Pennsylvania 19020 United States Details
West Virginia University RECRUITING Morgantown West Virginia 26506 United States Details
ProHealth Care Inc RECRUITING Waukesha Wisconsin 53188 United States Details
The Cancer Institute Hospital of JFCR RECRUITING Tokyo Koto City 135-8550 Japan Details
Niigata Cancer Center Hospital RECRUITING Chuo Ku Niigata Niigata 951-8566 Japan Details
Yamagata University Hospital RECRUITING Yamagata Yamagata 990-9585 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field